Sensititvity1 | P2 | Specificity1 | P3 | Positive PV1 | Negative PV1 | Positive LR4 | Negative LR4 | Diagnostic OR4 | |
---|---|---|---|---|---|---|---|---|---|
2017 NG12 referral criteria (n = 1479) | 98.9% (97.3–99.6) | 7.9% (6.4–9.7) | 30.9% (28.6–33.4) | 94.6% (87.3–98.0) | 1.07 (1.05–1.10) | 0.14 (0.06–0.3) | 7.9 (3.2–19.5) | ||
CG27 referral criteria (n = 821) | 58.3% (53.6–62.8) | p < 0.001 | 50.3% (47.3–53.3) | p < 0.001 | 32.9% (29.7–36.2) | 74.3% (71.0–77.4) | 1.17 (1.07–1.29) | 0.83 (0.73–0.94) | 1.4 (1.1–1.7) |
f-Hb ≥ 20 μg Hb/g faeces (n = 607) | 74.2% (70.0–78.1) | p < 0.001 | 76.1% (73.5–78.6) | p < 0.001 | 56.5% (52.4–60.5) | 87.6% (85.3–89.6) | 3.11 (2.76–3.50) | 0.34 (0.29–0.40) | 9.2 (7.1–11.8) |
f-Hb ≥ 10 μg Hb/g faeces (n = 696) | 79.4% (75.4–83.0) | p < 0.001 | 70.2% (67.4–72.9) | p < 0.001 | 52.7% (49.0–56.5) | 89.1% (86.8–91.0) | 2.67 (2.41–2.95) | 0.29 (0.24–0.35) | 9.1 (7.0–11.8) |
COLONPREDICT Score ≥ 5.6 (n = 463) | 64.2% (59.5–68.5) | p < 0.001 | 83.1% (80.7–85.2) | p < 0.001 | 61.4% (56.9–65.8) | 84.7% (82.3–86.7) | 3.79 (3.27–4.40) | 0.43 (0.38–0.49) | 8.8 (6.8–11.3) |
COLONPREDICT Score ≥ 3.2 (n = 994) | 88.7% (85.3–91.4) | p < 0.001 | 51.3% (48.3–54.3) | p < 0.001 | 43.3% (40.1–46.6) | 91.5% (89.0–93.6) | 1.82 (1.70–1.95) | 0.22 (0.17–0.29) | 8.3 (6.0–11.3) |
FAST Score ≥ 4.50 (n = 583) | 72.7% (68.4–76.7) | p < 0.001 | 77.8% (75.2–80.2) | p < 0.001 | 57.8% (53.7–61.9) | 87.2% (84.9–89.2) | 3.28 (2.90–3.71) | 0.35 (0.30–0.41) | 9.4 (7.3–12.0) |
FAST Score ≥ 2.12 (n = 1383) | 97.8% (95.9–98.9) | p = 1 | 16.1% (14.0–18.4) | p < 0.001 | 32.8% (30.3–35.3) | 94.7% (90.2–97.3) | 1.17 (1.13–1.2) | 0.13 (0.07–0.25) | 8.7 (4.5–16.5) |